Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer
Clinical trial NCT00540943 · COMPLETED
Trial details
- NCT number
- NCT00540943
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-13
- Primary completion
- 2010-05-03
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.